Ph.D.-trained biochemist with 12+ years of experience in immunology, sepsis biology, inflammatory disease, oncology, and reproductive research. Proven track record of advancing therapeutic candidates from mechanistic discovery through preclinical validation and leading programs supporting IND submissions and FDA regulatory approval pathways. Expert in immune cell signaling, macrophage polarization, oxidative stress pathways, and nanoparticle-based immunomodulatory platforms. Strong experience driving translational research strategy, biomarker development, and therapeutic efficacy evaluation in septic shock and systemic inflammatory conditions, with leadership in intellectual property development and patented technologies. Experienced in collaborative research settings, supporting cross-functional teams in aligning preclinical studies with regulatory considerations to facilitate steady pipeline advancement.